These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15545534)

  • 1. The use of custom-designed midfacial and submalar implants in the treatment of facial wasting syndrome.
    Binder WJ; Bloom DC
    Arch Facial Plast Surg; 2004; 6(6):394-7. PubMed ID: 15545534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction.
    Talmor M; Hoffman LA; LaTrenta GS
    Ann Plast Surg; 2002 Jul; 49(1):11-7; discussion 117-8. PubMed ID: 12142589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)].
    Claude O; Domergue Than Trong E; Blanc R; Ascher B; Bagot M; Meningaud JP; Lantieri L
    Ann Chir Plast Esthet; 2009 Feb; 54(1):21-8. PubMed ID: 19042066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-Fill to treat facial wasting.
    Cheonis N
    BETA; 2002; 15(2):10-5. PubMed ID: 12064301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of facial lipoatrophy via autologous fat transfer.
    Cohen G; Treherne A
    J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restorative interventions for HIV facial lipoatrophy.
    Carey D; Liew S; Emery S
    AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
    Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
    J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Care in Facial Implants.
    Floyd EM; Eppley B; Perkins SW
    Facial Plast Surg; 2018 Dec; 34(6):612-623. PubMed ID: 30593077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted technique for the design and manufacture of realistic facial prostheses.
    Feng Z; Dong Y; Zhao Y; Bai S; Zhou B; Bi Y; Wu G
    Br J Oral Maxillofac Surg; 2010 Mar; 48(2):105-9. PubMed ID: 19556041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical treatment of lipodystrophy].
    Claude O
    Rev Prat; 2010 Nov; 60(9):1235-40. PubMed ID: 21328855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated facial lipoatrophy: 18 months follow-up.
    Rauso R; Freda N; Parlato V; Gherardini G; Amore R; Tartaro G
    Dermatol Surg; 2011 Nov; 37(11):1584-9. PubMed ID: 21806709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malar and submalar augmentation.
    Binder WJ; Azizzadeh B
    Facial Plast Surg Clin North Am; 2008 Feb; 16(1):11-32, v. PubMed ID: 18063245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to treatment of HIV facial lipoatrophy.
    Jones D
    Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malar, submalar, and midfacial implants.
    Constantinides MS; Galli SK; Miller PJ; Adamson PA
    Facial Plast Surg; 2000; 16(1):35-44. PubMed ID: 11802345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
    Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
    J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice.
    Fisher K
    AIDS Read; 2001 Mar; 11(3):132-3, 137-40, 147. PubMed ID: 17004351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submalar augmentation. An alternative to face-lift surgery.
    Binder WJ
    Arch Otolaryngol Head Neck Surg; 1989 Jul; 115(7):797-801. PubMed ID: 2660851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.